Lab-made antibodies offer potential post-exposure measles therapy
TL;DR
Scientists isolated four potent monoclonal antibodies from a vaccinated donor’s blood that block measles by targeting the virus’s H and F proteins. In rodent tests, these antibodies reduced lung virus after exposure, suggesting potential post-exposure or preventive use, though they are not a substitute for vaccination and delivery challenges remain. Further testing is needed before any human therapy.
- As measles roars back, scientists find antibodies that could offer protection The Washington Post
- Researchers identify antibodies that may prevent and treat measles infections Reuters
- First measles treatment advances as vaccination rates drop BioWorld News
- New findings from La Jolla Institute for Immunology suggest a possible measles treatment San Diego Union-Tribune
- Scientists take crucial step in developing world's first measles treatment Medical Xpress
Want the full story? Read the original reporting
Read on The Washington Post